Work

Supplementary Tables S1-S2 and Supplementary Figure S1 from Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors

Year: 2023

Type: supplementary-materials

Abstract: Table S1. Cytotoxic activity in vitro in five cell lines; Table S2. In vivo toxicity of RITs; Fig S1. Cytotoxic activity in patients cells curves

DOI: 10.1158/1535-7163.22503261

Authors: Ronit Mazor, Jingli Zhang, Laiman Xiang, Selamawit Addissie, Prince Awuah, Richard Beers, Raffit Hassan, Ira Pastan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362527092

Cites:

Cited by:

Related to: 10